Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 5, 2003, Pages 958-966

  Sano, Yasuyuki ^a   Suzuki, Naohito ^a   Yamada, Hirokazu ^a   To, Yasuo ^a   Ogawa, Chuhei ^a   Ohta, Ken ^b   Adachi, Mitsuru ^c  

^a Doai Memorial Hospital   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SHOWA UNIVERSITY   (Japan)

Author keywords

Airway hyperresponsiveness; Airway inflammation; Airway remodeling; Bronchial asthma; EG2+ cells; Eosinophils; Induced sputum; Suplatast tosilate; TH2 type cytokines

Indexed keywords

CYTOKINE; HISTAMINE; SUPLATAST TOSYLATE;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; EOSINOPHIL; EXPIRATORY FLOW; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; LUNG FUNCTION TEST; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SPUTUM; SYMPTOMATOLOGY; T LYMPHOCYTE;

EID: 0038066616     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1415     Document Type: Article

References (26)

1. Bousquet J, Chanez P, Vignola AM, Lacoste JY, Michel FB. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
2. Busse WW, Sedgwiek JB. Eosinophils in asthma. Ann Allergy 1992;68:286-90.
3. Laitinen LA, Laitinen A, Haahtela T. Airway mucosa inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993;147:697-704.
4. Laitinen LA, Laitinen A. Inhaled corticosteroid treatment for asthma. Allergy Proc 1995;16:63-6.
5. Holgate ST. Asthma: past, present and future. Eur Respir J 1993;6:1507-20.
6. Chung KF, Durham SR. Asthma as an inflammatory disease: clinical perspectives. Br Med Bull 1992;48:179-89.
7. Fukuda T, Fukushima Y, Numao T, Ando N, Arima M, Nakajima H, et al. Role of interleukin-4 and vascular cell adhesion molecule-1 in selective eosinophil migration into the airways in allergic asthma. Am J Respir Cell Mol Biol 1996;14:84-94.
8. Yanagihara Y, Kiniwa M, Ikizawa K, Shida T, Matsuura N, Koda A. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (2). Regulation of human IgE response. Jpn J Pharmacol 1993;61:31-9.
9. Yamaya H, Basaki Y, Togawa M, Kojima M, Kiniwa M, Matsuura N. Down-regulation of Th2 cell-mediated murine peritoneal eosinophilia by antiallergic agents. Life Sci 1995;56:1647-54.
10. Makino S, Kosho M, Miyamoto T. Guideline for prevention and management of asthma. 1st ed. Tokyo: Kyowa Kikaku Tsushin; 1998.
11. National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institute of Health; 1997. NIH publication no. 97-4051.
12. Makino S, Kobayashi S, Miyamoto T, Shida T, Takahashi S. Standard for allergen bronchial provocation tests in asthma and hypersensitivity pneumonitis. Arerugi 1982;31:1074-6.
13. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992;47:25-9.
14. Hansel TT, Braunstein JB, Walker C, Blaser K, Bruijnzeel PL, Virchow JC Jr, et al. Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR. Clin Exp Immunol 1991;86:271-7.
15. Watanabe A, Mishima H, Renzi PM, Xu LJ, Hamid Q, Martin JG. Transfer of allergic airway responses with antigen-primed CD4+ but not CD8+ T cells in brown Norway rats. J Clin Invest 1995;96:1303-10.
16. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
17. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
18. Corrigan CJ, Kay AB. T-cell/eosinophil interactions in the induction of asthma. Eur Respir J Suppl 1996;9:72s-8s.
19. Sano Y, Miyamoto Y, Makino S. Anti-inflammatory effect of suplatast tosilate on mild asthma. Chest 1997;112:862-3.
20. Kusumoto H, Mizuno K, Yonemaru M, Nakano M, Ichinose Y, Toyama K. Successful treatment of chronic eosinophilic pneumonia with suplatast tosilate. Nihon Kyobu Shikkan Gakkai Zasshi 1997;35:550-4.
21. Hamada H, Sakatani M, Nishioka M, Akira M, Yamamoto S, Ueda E, et al. Chronic eosinophilic pneumonia successfully treated with suplatast tosilate. Nihon Kyobu Shikkan Gakkai Zasshi 1997;35:692-7.
22. Taniguchi H, Togawa M, Ohwada K, Kiniwa M, Matsuura N, Nagai H, et al. Suplatast tosilate, a new type of antiallergic agent, prevents the expression of airway hyperresponsiveness in guinea pigs. Eur J Pharmacol 1996;318:447-54.
23. Iijima H, Tamura G, Hsiue TR, Liu Y, Taniguchi H, Shirato K. Suplatast tosilate inhibits late response and airway inflammation in sensitized guinea pigs. Am J Respir Crit Care Med 1999;160:331-5.
24. Kobayashi Y, Nagata M, Yamamoto H, Sakamoto Y. Inhibitory effect of suplatast tosilate on eosinophil migration. Arerugi 2000;49:600-3.
25. Tamaoki J, Kondo M, Sakai N, Aoshiba K, Tagaya E, Nakata J, et al. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group. Lancet 2000;356:273-8.
26. Chetta A, Foresi A, Del Donno M, Bertorelli G, Pesci A, Olivieri D. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 1997;111:852-7.